Literature DB >> 32027839

Multiple Input Sensing and Signal Integration Using a Split Cas12a System.

Hannah R Kempton1, Laine E Goudy1, Kasey S Love1, Lei S Qi2.   

Abstract

The ability to integrate biological signals and execute a functional response when appropriate is critical for sophisticated cell engineering using synthetic biology. Although the CRISPR-Cas system has been harnessed for synthetic manipulation of the genome, it has not been fully utilized for complex environmental signal sensing, integration, and actuation. Here, we develop a split dCas12a platform and show that it allows for the construction of multi-input, multi-output logic circuits in mammalian cells. The system is highly programmable and can generate expandable AND gates with two, three, and four inputs. It can also incorporate NOT logic by using anti-CRISPR proteins as an OFF switch. By coupling the split dCas12a design to multiple tumor-relevant promoters, we provide a proof of concept that the system can implement logic gating to specifically detect breast cancer cells and execute therapeutic immunomodulatory responses.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AND gates; Boolean logic; CRISPR-Cas; Cpf1; cell engineering; genetic circuits; immunotherapy; logic gates; split Cas12a; synthetic biology

Mesh:

Substances:

Year:  2020        PMID: 32027839     DOI: 10.1016/j.molcel.2020.01.016

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  13 in total

1.  Scalable biological signal recording in mammalian cells using Cas12a base editors.

Authors:  Hannah R Kempton; Kasey S Love; Lucie Y Guo; Lei S Qi
Journal:  Nat Chem Biol       Date:  2022-05-30       Impact factor: 16.174

Review 2.  Dual Systems for Enhancing Control of Protein Activity through Induced Dimerization Approaches.

Authors:  Sarah Pearce; Chandra L Tucker
Journal:  Adv Biol (Weinh)       Date:  2021-01-14

Review 3.  Controlling and enhancing CRISPR systems.

Authors:  Haridha Shivram; Brady F Cress; Gavin J Knott; Jennifer A Doudna
Journal:  Nat Chem Biol       Date:  2020-12-16       Impact factor: 15.040

4.  Toward a translationally independent RNA-based synthetic oscillator using deactivated CRISPR-Cas.

Authors:  James Kuo; Ruoshi Yuan; Carlos Sánchez; Johan Paulsson; Pamela A Silver
Journal:  Nucleic Acids Res       Date:  2020-08-20       Impact factor: 16.971

5.  A CRISPR-Cas autocatalysis-driven feedback amplification network for supersensitive DNA diagnostics.

Authors:  Kai Shi; Shiyi Xie; Renyun Tian; Shuo Wang; Qin Lu; Denghui Gao; Chunyang Lei; Haizhen Zhu; Zhou Nie
Journal:  Sci Adv       Date:  2021-01-27       Impact factor: 14.136

6.  Strong and tunable anti-CRISPR/Cas activities in plants.

Authors:  Camilo Calvache; Marta Vazquez-Vilar; Sara Selma; Mireia Uranga; Asun Fernández-Del-Carmen; José-Antonio Daròs; Diego Orzáez
Journal:  Plant Biotechnol J       Date:  2021-10-31       Impact factor: 9.803

7.  Multiplexed activation in mammalian cells using a split-intein CRISPR/Cas12a based synthetic transcription factor.

Authors:  James W Bryson; Jamie Y Auxillos; Susan J Rosser
Journal:  Nucleic Acids Res       Date:  2022-01-11       Impact factor: 16.971

8.  A far-red light-inducible CRISPR-Cas12a platform for remote-controlled genome editing and gene activation.

Authors:  Xinyi Wang; Kaili Dong; Deqiang Kong; Yang Zhou; Jianli Yin; Fengfeng Cai; Meiyan Wang; Haifeng Ye
Journal:  Sci Adv       Date:  2021-12-10       Impact factor: 14.136

9.  Enhanced Cas12a multi-gene regulation using a CRISPR array separator.

Authors:  Jens P Magnusson; Antonio Ray Rios; Lingling Wu; Lei S Qi
Journal:  Elife       Date:  2021-09-09       Impact factor: 8.140

10.  Precise tumor immune rewiring via synthetic CRISPRa circuits gated by concurrent gain/loss of transcription factors.

Authors:  Yafeng Wang; Guiquan Zhang; Qingzhou Meng; Shisheng Huang; Panpan Guo; Qibin Leng; Lingyun Sun; Geng Liu; Xingxu Huang; Jianghuai Liu
Journal:  Nat Commun       Date:  2022-03-18       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.